Literature DB >> 33372290

Exosomes in Parkinson disease.

Jennifer R Pinnell1,2, Mei Cui3, Kim Tieu1,4.   

Abstract

Parkinson disease (PD) is a prevalent neurodegenerative disease, in which the formation of misfolded and aggregated α-synuclein is a key neuropathological hallmark. Recent studies reveal that extracellular vesicles such as exosomes present a potential mechanism for propagation of pathological α-synuclein throughout the brain. The ability of exosomes to transport proteins and genetic material between cells, including mRNA and microRNAs which have been implicated in PD pathology, provides critical insights as to how exosomes may contribute to pathological progression in PD. Advances have also been made in the investigation of exosomes as potential tools for the modulation of Parkinson's pathology; their detection extracellularly may facilitate their use as biomarkers, while their small size could be utilised as vectors for the delivery of therapeutics. The aim of this review was to highlight our current knowledge of the role of exosomes in PD and potential clinical application.
© 2020 International Society for Neurochemistry.

Entities:  

Keywords:  Parkinson disease; alpha-synuclein; exosomes; extracellular vesicles; neurodegeneration; protein aggregation

Mesh:

Substances:

Year:  2021        PMID: 33372290      PMCID: PMC8863192          DOI: 10.1111/jnc.15288

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  137 in total

Review 1.  The interplay between exosomes and autophagy - partners in crime.

Authors:  Jing Xu; Robert Camfield; Sharon M Gorski
Journal:  J Cell Sci       Date:  2018-08-03       Impact factor: 5.285

Review 2.  The biology, function, and biomedical applications of exosomes.

Authors:  Raghu Kalluri; Valerie S LeBleu
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

3.  CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease.

Authors:  Min Shi; Andrej Kovac; Ane Korff; Travis J Cook; Carmen Ginghina; Kristin M Bullock; Li Yang; Tessandra Stewart; Danfeng Zheng; Patrick Aro; Anzari Atik; Kathleen F Kerr; Cyrus P Zabetian; Elaine R Peskind; Shu-Ching Hu; Joseph F Quinn; Douglas R Galasko; Thomas J Montine; William A Banks; Jing Zhang
Journal:  Alzheimers Dement       Date:  2016-05-24       Impact factor: 21.566

4.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

Authors:  M H Polymeropoulos; C Lavedan; E Leroy; S E Ide; A Dehejia; A Dutra; B Pike; H Root; J Rubenstein; R Boyer; E S Stenroos; S Chandrasekharappa; A Athanassiadou; T Papapetropoulos; W G Johnson; A M Lazzarini; R C Duvoisin; G Di Iorio; L I Golbe; R L Nussbaum
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

5.  Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.

Authors:  Yaping Chu; Scott Muller; Adriana Tavares; Olivier Barret; David Alagille; John Seibyl; Gilles Tamagnan; Ken Marek; Kelvin C Luk; John Q Trojanowski; Virginia M Y Lee; Jeffrey H Kordower
Journal:  Brain       Date:  2019-11-01       Impact factor: 13.501

6.  Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.

Authors:  Changyoun Kim; Dong-Hwan Ho; Ji-Eun Suk; Sungyong You; Sarah Michael; Junghee Kang; Sung Joong Lee; Eliezer Masliah; Daehee Hwang; He-Jin Lee; Seung-Jae Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 7.  Exosomes and their role in the intercellular trafficking of normal and disease associated prion proteins.

Authors:  Lesley Cheng; Wenting Zhao; Andrew F Hill
Journal:  Mol Aspects Med       Date:  2017-12-08

8.  MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson's Disease.

Authors:  Yimeng Chen; Chao Gao; Qian Sun; Hong Pan; Pei Huang; Jianqing Ding; Shengdi Chen
Journal:  Front Aging Neurosci       Date:  2017-07-21       Impact factor: 5.750

9.  Exosomal cell-to-cell transmission of alpha synuclein oligomers.

Authors:  Karin M Danzer; Lisa R Kranich; Wolfgang P Ruf; Ozge Cagsal-Getkin; Ashley R Winslow; Liya Zhu; Charles R Vanderburg; Pamela J McLean
Journal:  Mol Neurodegener       Date:  2012-08-24       Impact factor: 14.195

10.  Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein.

Authors:  He-Jin Lee; Eun-Duk Cho; Kyung Won Lee; Jung-Hyun Kim; Ssang-Goo Cho; Seung-Jae Lee
Journal:  Exp Mol Med       Date:  2013-05-10       Impact factor: 8.718

View more
  14 in total

1.  Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia.

Authors:  Shicong Zhu; Cheng Xing; Ruijuan Li; Zhao Cheng; Mingyang Deng; Yunya Luo; Heng Li; Guangsen Zhang; Yue Sheng; Hongling Peng; Zhihua Wang
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

2.  Association Between Mitochondrial Function and Rehabilitation of Parkinson's Disease: Revealed by Exosomal mRNA and lncRNA Expression Profiles.

Authors:  Yixuan Wang; Yonghong Liu; Zhaohui Jin; Cui Liu; Xin Yu; Keke Chen; Detao Meng; Aixian Liu; Boyan Fang
Journal:  Front Aging Neurosci       Date:  2022-06-16       Impact factor: 5.702

3.  Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson's Disease.

Authors:  Elena Vacchi; Jacopo Burrello; Alessio Burrello; Sara Bolis; Silvia Monticone; Lucio Barile; Alain Kaelin-Lang; Giorgia Melli
Journal:  Biomedicines       Date:  2021-02-25

4.  Neurodegenerative Disease-Associated TDP-43 Fragments Are Extracellularly Secreted with CASA Complex Proteins.

Authors:  Elena Casarotto; Daisy Sproviero; Eleonora Corridori; Maria Cristina Gagliani; Marta Cozzi; Marta Chierichetti; Riccardo Cristofani; Veronica Ferrari; Mariarita Galbiati; Francesco Mina; Margherita Piccolella; Paola Rusmini; Barbara Tedesco; Stella Gagliardi; Katia Cortese; Cristina Cereda; Angelo Poletti; Valeria Crippa
Journal:  Cells       Date:  2022-02-02       Impact factor: 6.600

5.  Celastrol Downmodulates Alpha-Synuclein-Specific T Cell Responses by Mediating Antigen Trafficking in Dendritic Cells.

Authors:  Lam Ng; Xiaohui Wang; Chuanbin Yang; Chengfu Su; Min Li; Allen Ka Loon Cheung
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 8.786

6.  Diagnostic Test to Identify Parkinson's Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study.

Authors:  Guangan Tong; Pingping Zhang; Wenbin Hu; Kun Zhang; Xianwen Chen
Journal:  Parkinsons Dis       Date:  2022-04-06

Review 7.  Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.

Authors:  Pedro Magalhães; Hilal A Lashuel
Journal:  NPJ Parkinsons Dis       Date:  2022-07-22

Review 8.  View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson's Disease: Are We on the Right Track?

Authors:  Thomas Müller
Journal:  Biologics       Date:  2021-07-29

9.  Immuno-Acoustic Sorting of Disease-Specific Extracellular Vesicles by Acoustophoretic Force.

Authors:  Junyuan Liu; Yuxin Qu; Han Wang
Journal:  Micromachines (Basel)       Date:  2021-12-09       Impact factor: 2.891

Review 10.  Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies.

Authors:  Zhimin Yang; Yanyu Li; Zihua Wang
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.